94,020 Shares in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS) Purchased by Verition Fund Management LLC

Verition Fund Management LLC bought a new position in shares of DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALSGet Rating) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 94,020 shares of the company’s stock, valued at approximately $917,000. Verition Fund Management LLC owned 0.37% of DA32 Life Science Tech Acquisition at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Spartan Fund Management Inc. purchased a new position in shares of DA32 Life Science Tech Acquisition during the first quarter valued at approximately $181,000. Ursa Fund Management LLC acquired a new stake in DA32 Life Science Tech Acquisition during the 1st quarter valued at $243,000. Piper Sandler & CO. acquired a new stake in DA32 Life Science Tech Acquisition during the 1st quarter valued at $244,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in DA32 Life Science Tech Acquisition during the 1st quarter valued at $486,000. Finally, Exos Asset Management LLC acquired a new stake in DA32 Life Science Tech Acquisition during the 4th quarter valued at $722,000. 60.43% of the stock is currently owned by institutional investors and hedge funds.

DA32 Life Science Tech Acquisition Price Performance

Shares of DALS stock opened at $9.79 on Thursday. DA32 Life Science Tech Acquisition Corp. has a 1-year low of $9.58 and a 1-year high of $10.26. The firm has a fifty day moving average of $9.73 and a two-hundred day moving average of $9.71.

About DA32 Life Science Tech Acquisition

(Get Rating)

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.

Further Reading

Institutional Ownership by Quarter for DA32 Life Science Tech Acquisition (NASDAQ:DALS)

Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.